Intricon Corp
NASDAQ:IIN
Intricon Corp
Revenue
Intricon Corp
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Intricon Corp
NASDAQ:IIN
|
Revenue
$126.5m
|
CAGR 3-Years
2%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Intricon Corp
Revenue Breakdown
Breakdown by Geography
Intricon Corp
Total Revenue:
125.2m
USD
|
United States:
92.9m
USD
|
All Other Countries:
13.2m
USD
|
Asia:
12.6m
USD
|
Europe:
6.6m
USD
|
Breakdown by Segments
Intricon Corp
See Also
What is Intricon Corp's Revenue?
Revenue
126.5m
USD
Based on the financial report for Mar 31, 2022, Intricon Corp's Revenue amounts to 126.5m USD.
What is Intricon Corp's Revenue growth rate?
Revenue CAGR 5Y
12%
Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for Intricon Corp have been 2% over the past three years , 12% over the past five years .